CI
PACB icon

Cowen Inc’s Pacific Biosciences PACB Stock Holding History

Cowen Inc’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$1.84M Buy
304,791
+184,591
+154% +$1.29M 0.13% 120
2019
Q1 		$869K Buy
120,200
+20,540
+21% +$149K 0.09% 123
2018
Q4 		$737K Buy
+99,660
New +$631K 0.08% 152
2014
Q4 		– Sell
-15,000
Closed -$74K – 279
2014
Q3 		$74K Buy
+15,000
New +$78.4K 0.01% 281
2014
Q2 		– Sell
-10,100
Closed -$54K – 269
2014
Q1 		$54K Buy
+10,100
New +$63.8K 0.01% 187

Other funds holding PACB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Cowen Inc's PACB Position: Q2 2019 in Review

Cowen Inc increased its Pacific Biosciences (PACB) stake by 154% in Q2 2019, buying an estimated $1.29M and bringing the position to 304,791 shares worth $1.84M. The position accounts for 0.13% of the portfolio, ranked #120.

Cowen Inc first reported a position in PACB in Q1 2014 and has held it in 5 quarters since. 150 funds tracked by Wall St. Rank hold PACB as of Q2 2019.

  • Cowen Inc held 304,791 shares of Pacific Biosciences worth $1.84M as of Q2 2019.
  • Cowen Inc bought 184,591 Pacific Biosciences shares in Q2 2019, an estimated $1.29M.
  • Pacific Biosciences made up 0.13% of Cowen Inc's portfolio in Q2 2019, its #120 holding.
  • Cowen Inc first reported a position in Pacific Biosciences in Q1 2014 and has held it in 5 quarters since.
  • 150 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.